Sun, J.X.,
Sun, Z.Y.,
Gareev, I,
Yan, T,
Chen, X,
Ahmad, A,
Zhang, D.M.,
Zhao, B.X.,
Beylerli, O.,
Yang, G.,
Zhao, S.G. (2021) . Bioinformatic analyses were performed to identify a gene
target, and CGGA and TCGA databases were checked
Han, Z.B.,
Wang, X.X.,
Xu, Z.H.,
Cao, Y.,
Gong, R,
Zagidullin, N.,
Sukhareva, N.,
Zhang, Y. (2021) a novel potential
therapeutic strategy for cardiac regeneration.
Karasev, S.M.,
Sufianov, A.A.,
Khafizov, R.R.,
Karaseva, I.I.,
Shugushev, Z.K.,
Maximkin, D.A.,
Khafizov, T.N. (2021) common pathology, which remains one of the most diagnostically and
therapeutically complex diseases
Gareev, Ilgiz,
Beylerli, Ozal,
Yang, Guang,
Izmailov, Adel,
Shi, Huaizhang,
Sun, Jinxian,
Zhao, Boxian,
Liu, Binbing,
Zhao, Shiguang (2021) '-untranslated regions (3 ' UTRs) of the
target mRNAs. MiRNAs are involved in the pathogenesis of IAs, including
Yagudin, T,
Zhao, Y,
Gao, HY,
Zhang, Y,
Yang, Y,
Zhang, XF,
Ma, WB,
Daba, TM,
Ishmetov, V,
Kang, K,
Yang, BF,
Pan, ZW (2021) ASPP is an important regulator of cardiomyocyte apoptosis, which represents a potential
target in the therapy
Boyko, A.N.,
Bakhtiyarova, K.Z.,
Brylev, L.V.,
Zakharova, M.N.,
Kasatkin, D.S.,
Korobko, D.S.,
Kotov, S.V.,
Krasnov, V.S.,
Malkova, N.A.,
Popova, E.V.,
Sivertseva, S.A.,
Simaniv, T.O.,
Sokolova, A.A.,
Totolyan, N.A.,
Trushnikova, T.N.,
Khabirov, F.A.,
Khachanova, N.V. (2021) and routing of patients, and
therapeutic approaches to this disease need to be improved. During several expert
Coignard, J.,
Lush, M.,
Beesley, J.,
O’Mara, T.A.,
Dennis, J,
Tyrer, J.P.,
Barnes, D.R.,
McGuffog, L.,
Leslie, G.,
Bolla, M.K.,
Adank, M.A.,
Kiiski, J.I.,
Nevanlinna, H.,
team of authors (2021) previously implicated in BC biology, are predicted as potential
targets. These findings will contribute